Dyspepsia

(redirected from Nonulcer dyspepsia)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.

DYSPEPSIA, med. jur., contracts. A state of the stomach in which its functions are disturbed, without the presence of other diseases; or when, if other diseases are present, they are of minor importance. Dunglison's Med. Dict. h.t.
     2. Dyspepsia is not, in general, considered as a disease which tends to shorten life, so as to make a life uninsurable; unless the complaint has become organic dyspepsia, or was of such a degree at the time of the insurance, as, by its excess, to tend to shorten life. 4 Taunt. 763.

References in periodicals archive ?
Comparison of endoscopic diagnostic yield between untrained physicians [non-gastroenterologists] and trained physicians [gastroenterologists] showed that there was no difference in the proportion of patients having duodenal ulcer and nonulcer dyspepsia [NUD] (p=0.575).Similarly there was no difference in results of RUT (p=0.570) performed by different types of physicians (Table 2).
In a recent, randomized, placebo-controlled trial in a developed country, eradication therapy proved successful in a subset of patients with nonulcer dyspepsia (19).
pylori treatment for symptomatic nonulcer dyspepsia patients in whom upper GI endoscopy has revealed minimal or no mucosal defects.
Treating H pylori in patients with nonulcer dyspepsia reduces symptoms, but doesn't improve quality of life in the short term (SOR: B, systematic review of randomized controlled trials [RCTs] with inconsistent results), but may alleviate symptoms in the long term (SOR: B, RCT with methodological flaws).
Indications for treatment included peptic ulcer disease (37%), nonulcer dyspepsia (46.6%), gastroesophageal reflux disease (2.7%), and other diagnoses (13.7%).
from Japan reported that strains with partial deletions within the cag-PAI were only derived from patients with nonulcer dyspepsia, whereas strains with an intact cag-PAI originated only from patients with gastric carcinoma [11].
Indications carried forward from the prior edition included peptic ulcer disease, nonulcer dyspepsia, mucosa-associated lymphoid tissue (MALT) lymphoma, atrophic gastritis, a history of gastric cancer resection, first-degree relatives of patients with gastric cancer, and patients who, on consulting with a physician, want to be tested.
Other indications include peptic ulcer disease, nonulcer dyspepsia, mucosa-associated lymphoid tissue (MALT) lymphoma, atrophic gastritis, a history of gastric cancer resection, first-degree relatives of patients with gastric cancer, and patients who, on consulting with a physician, want to be tested.
pylori-positive individuals who have nonulcer dyspepsia, an approach for which Dr.
* OBJECTIVE To determine how often primary care physicians prescribe eradication therapy for peptic ulcer disease (PUD) and nonulcer dyspepsia (NUD).
Eradication of Helicobacter pylori might be cost effective for treating select patients with nonulcer dyspepsia, reported Dr.